MV

Maryann Veronica Menezes

Active Director Whole-Time Director DIN 00145980
DIN 00145980 First appointment Apr 2006 Primary industry Financial Services
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since Apr 2006
Shareholding value •••• Premium profile

About Maryann Veronica Menezes

Data last updated:

Maryann Veronica Menezes is a Whole-Time Director at Cfl Pharmaceuticals Limited (since 2012), Director at Menezes Remedies Limited (since 2012) and Director at Menezes Pharmaceuticals Limited (since 2006), and holds 3 more current directorships. The companies operate in Financial Services, Pharma and Agriculture. The 5 current companies with reported revenue have a combined latest revenue of ₹237 Cr; the largest is Cfl Pharmaceuticals Limited at ₹202 Cr (FY 2025).

DIN 00145980
Primary Designation Whole-Time Director
Industry Financial Services
First Appointment 25 Apr 2006
Oldest Company Age 45 yrs
Largest company Cfl Pharmaceuticals Limited · ₹202 Cr (FY 2025)
Combined revenue ₹237 Cr across 5 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Cfl Pharmaceuticals Limited U24246GA1981PLC000465
Whole-Time Director30 Nov 20121981₹202 Cr (FY 2025)Active
Menezes Remedies Limited U52311GA1996PLC002041
Director31 Aug 20121996₹17.69 Cr (FY 2025)Active
Menezes Pharmaceuticals Limited U24232GA1996PLC002040
Director25 Apr 20061996₹17.15 Cr (FY 2025)Active
Cosme Bio-Tech Private Limited U31200GA1997PTC002440
Director26 Nov 20121997₹50.3 Lakh (FY 2025)Active
Director10 Apr 20131992₹50,408 (FY 2017)Active
Director29 Apr 20131996Active

Directorship timeline

Open interactive timeline →
Menezes Pharmaceuticals Limited
Frederick Electro Devices Private Limited
Cosme Bio-Tech Private Limited
Menezes Remedies Limited
Premium access

Shareholding and investment profile for Maryann Veronica Menezes

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maryann Veronica Menezes

Maryann Veronica Menezes currently holds 6 directorships: Cfl Pharmaceuticals Limited (Whole-Time Director, since 30 Nov 2012, revenue ₹202 Cr (FY 2025)); Menezes Remedies Limited (Director, since 31 Aug 2012, revenue ₹17.69 Cr (FY 2025)); Menezes Pharmaceuticals Limited (Director, since 25 Apr 2006, revenue ₹17.15 Cr (FY 2025)); Cosme Bio-Tech Private Limited (Director, since 26 Nov 2012, revenue ₹50.3 Lakh (FY 2025)); Frederick Electro Devices Private Limited (Director, since 10 Apr 2013, revenue ₹50,408 (FY 2017)); and 1 more.

Maryann Veronica Menezes was first appointed on 25 Apr 2006 as Director at Menezes Pharmaceuticals Limited. The most recent appointment on record is 29 Apr 2013 at Cosme Stocks And Credits Private Limited.

The 5 current companies of Maryann Veronica Menezes that report revenue have a combined latest revenue of ₹237 Cr: Cfl Pharmaceuticals Limited ₹202 Cr (FY 2025); Menezes Remedies Limited ₹17.69 Cr (FY 2025); Menezes Pharmaceuticals Limited ₹17.15 Cr (FY 2025); Cosme Bio-Tech Private Limited ₹50.3 Lakh (FY 2025); Frederick Electro Devices Private Limited ₹50,408 (FY 2017).

The current boards of Maryann Veronica Menezes's companies include Brenda Juliette Nazareth Menezes (Cfl Pharmaceuticals Limited), Christine Stephanie Menezes (Cfl Pharmaceuticals Limited), Peter Mark Menezes (Menezes Remedies Limited), Sandesh Anant Kamat Bambolkar (Cosme Bio-Tech Private Limited), Andre Jose Joao De Menezes (Cosme Stocks And Credits Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available